Laga assists national and international investors syndicate with Series A Financing Round

Taking on your challenges

14 April 2016

Laga assisted an investors’ syndicate of national and international investors (LSP V COÖPERATIEVE U.A, BOEHRINGER INGELHEIM VENTURE FUND GMBH, PARTICIPATIEMAATSCHAPPIJ VLAANDEREN NV, OMEGA FUND V, L.P. and FUND+ NV) in connection with the negotiation and implementation of a EUR 24 million Series A Financing Round in eTheRNA NV.

eTheRNA immunotherapies is a spin-off from the Brussels University 'Vrije Universiteit Brussel' (VUB). This investment will enable the company to continue the development of its innovative immunotherapies to treat melanoma, breast cancer and infectious diseases.

The team from the Corporate - M&A practice was led by Christoph Michiels and included Maxime Schurmans.

Did you find this useful?